Latest Information Update: 16 Nov 1994
At a glance
- Originator Retrogen Medical
- Class Antivirals
- Mechanism of Action RNA synthesis inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- No development reported HIV infections
Most Recent Events
- 16 Nov 1994 No-Development-Reported for HIV infections treatment in USA (Unknown route)